Physician profile
Faisal Shaikh
NPI 1669890844
$67,363.72
in general payments reported to CMS, 2019-2025
11 companies · $37K in 2025
The $37K reported for 2025 was more than what 97% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.76 · 2020: $13K · 2021: $2,125 · 2022: $12K · 2023: $354 · 2024: $2,982 · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $27K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Travel and Lodging: $5,867 · Food and Beverage: $1,579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $27,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Travel and Lodging | $5,866.99 |
| Food and Beverage | $1,579.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $51,281.62 | 2020-2025 | Da Vinci Surgical System |
| Boston Scientific Corporation | $12,500.00 | 2020 | |
| Medtronic, INC. | $1,329.09 | 2021-2022 | |
| Pulmonx Corporation | $916.99 | 2021-2024 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Ambu A/S | $637.50 | 2022 | |
| Olympus America INC. | $192.06 | 2021 | |
| Serpex Medical INC | $184.59 | 2025 | |
| Intra-Sana Laboratories | $137.00 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Galvanize Therapeutics, INC | $116.51 | 2024-2025 | Aliya System |
| Ethicon INC. | $42.60 | 2021 | |
| Olympus Corporation of The Americas | $25.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faisal Shaikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.